
- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
Sotrastaurin (AEB071) 是一種有效的,選擇性的泛PKC抑制劑,最有效作用于PKCθ,無細胞試驗中Ki為0.22 nM;對PKCζ沒有活性。Phase 2。
Sotrastaurin (AEB071) Chemical Structure
CAS: 425637-18-9
| 細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息(PMID) |
|---|---|---|---|---|---|
| 92.1 | Growth Inhibition Assay | 0-5 μM | 72 h | inhibits cell growth dose dependently | 22653968 |
| Omm1.3 | Growth Inhibition Assay | 0-5 μM | 72 h | inhibits cell growth dose dependently | 22653968 |
| Mel202 | Growth Inhibition Assay | 0-5 μM | 72 h | inhibits cell growth dose dependently | 22653968 |
| CD3+ T? | Function Assay | 0-500 nM | 1 h | inhibits NF-κB phosphorylation in a dose dependent manner | 23573283 |
| SP49 | Function Assay | 2.5 μM? | 12 h | downregulates NF-κB target genes | 24362935 |
| Rec-1 | Function Assay | 2.5 μM? | 12 h | downregulates NF-κB target genes | 24362935 |
| Mino | Function Assay | 2.5 μM? | 12 h | downregulates NF-κB target genes | 24362935 |
| Jeko-1 | Function Assay | 2.5 μM? | 12 h | downregulates NF-κB target genes | 24362935 |
| OCM3 | Growth Inhibition Assay | 0.5 μM | 3 h | increases IR-induced cell cycle arrest? | 24595385 |
| 92.1 | Growth Inhibition Assay | 0.5 μM | 3 h | increases IR-induced cell cycle arrest? | 24595385 |
| Mel202 | Growth Inhibition Assay | 0.5 μM | 3 h | increases IR-induced cell cycle arrest? | 24595385 |
| OCM3 | Growth Inhibition Assay | 0.5 μM | 3 h | enhances IR-induced reduction in cell viability | 24595385 |
| 92.1 | Growth Inhibition Assay | 0.5 μM | 3 h | enhances IR-induced reduction in cell viability | 24595385 |
| Mel202 | Growth Inhibition Assay | 0.5 μM | 3 h | enhances IR-induced reduction in cell viability | 24595385 |
| A549 | Growth Inhibition Assay | 0.1?μM | 24 h | enhances growth inhibition cotreated with AS-IV | 25218161 |
| A549 | Function Assay | 0.1?μM | 24 h | reduces the expression levels of MMP-2, MMP-9 and integrin β1 | 25218161 |
| A549 | Function Assay | 0.1?μM | 24 h | decreases the relative PKC-α level on cell membrane cotreated AS-IV | 25218161 |
| HUVECs? | Function Assay | 500nM | 1 h | Reduces DTX-Triggered Endothelial Dysfunction | 25634538 |
| T cell | Function Assay | 100 nM | 3 h | inhibits rRNA synthesis | 25691158 |
| Mel202 | Growth Inhibition Assay | 5 μM | 24 h | induces G1 arrest? | 22653968 |
| Omm1.3 | Growth Inhibition Assay | 5 μM | 24 h | induces G1 arrest? | 22653968 |
| 92.1 | Growth Inhibition Assay | 5 μM | 24 h | induces G1 arrest? | 22653968 |
| Mel202 | Apoptosis Assay | 5 μM | 72 h | induces apoptosis slightly | 22653968 |
| Omm1.3 | Apoptosis Assay | 5 μM | 72 h | induces apoptosis | 22653968 |
| 92.1 | Apoptosis Assay | 5 μM | 72 h | induces apoptosis signifcantly | 22653968 |
| Mel202 | Function Assay | 5 μM | 24 h | inhibits expression and phosphorylation of PKC isoforms | 22653968 |
| Omm1.3 | Function Assay | 5 μM | 24 h | inhibits expression and phosphorylation of PKC isoforms | 22653968 |
| 92.1 | Function Assay | 5 μM | 24 h | inhibits expression and phosphorylation of PKC isoforms | 22653968 |
| HBL1 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50=0.5 μM | 21324920 |
| TMD8 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50=0.2 μM | 21324920 |
| OCI-Ly10 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50=1.3 μM | 21324920 |
| U2932 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50=10 μM | 21324920 |
| OCI-Ly3 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50>20 μM | 21324920 |
| SuDHL2 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50>20 μM | 21324920 |
| SuDHL4 | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50>20 μM | 21324920 |
| DB | Growth Inhibition Assay | 0.16-20 μM | 5 d | IC50>20 μM | 21324920 |
| SP49 | Growth Inhibition Assay | 0-4 μM | inhibits cell growth dose dependently | 24362935 | |
| Rec-1 | Growth Inhibition Assay | 0-4 μM | inhibits cell growth dose dependently | 24362935 | |
| Mino | Growth Inhibition Assay | 0-4 μM | inhibits cell growth dose dependently | 24362935 | |
| Jeko-1 | Growth Inhibition Assay | 0-4 μM | inhibits cell growth dose dependently | 24362935 | |
| Jurkat T | Function assay | 5 hrs | Inhibition of PKCtheta in human Jurkat T cells assessed as reduction in anti-CD3/CD28 antibody-induced T-cell activation by measuring decrease in IL-2 secretion after 5 hrs by luciferase reporter gene assay, IC50 = 0.081 μM. | 28131714 | |
| bone marrow cells | Antiproliferative assay | 4 days | Antiproliferative activity against CBA mouse bone marrow cells assessed as inhibition of [3H]thymidine incorporation after 4 days, IC50 = 3.7 μM. | 19827831 | |
| Jurkat IL-2 | Growth Inhibition Assay | IC50=6.71 ± 3.76 μM | 19940259 | ||
| PBMC IL-2 | Growth Inhibition Assay | IC50=4.84 ± 1.70 μM | 19940259 | ||
| Jurkat | Function assay | Inhibition of TCR/CD28-mediated human T cell activation in Jurkat cells expressing human IL2 promoter by luciferase reporter gene assay, IC50 = 0.054 μM. | 19827831 | ||
| B-cells | Function assay | Inhibition of PKCbeta in mouse B cells assessed as reduction in IgM-stimulated cell proliferation, IC50 = 0.234 μM. | 28131714 | ||
| 點擊查看更多細胞系數(shù)據(jù) | |||||
| 產(chǎn)品描述 | Sotrastaurin (AEB071) 是一種有效的,選擇性的泛PKC抑制劑,最有效作用于PKCθ,無細胞試驗中Ki為0.22 nM;對PKCζ沒有活性。Phase 2。 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 特性 | 同以往的PKC抑制劑不同,AEB071并不會在激活誘導的細胞死亡模型中增強鼠T細胞原幼細胞的凋亡。 | |||||||||||
| 靶點 |
|
| 體外研究(In Vitro) | ||||
| 體外研究活性 | 在人和鼠的早期T細胞中,毫微摩爾級濃度的AEB071 (< 10μM)則能有效消除早期T細胞激活的信號如白介素-2分泌物和CD25表達。在沒發(fā)生非特異性抗增殖的效應的細胞中,AEB071 (200 nM)能抑制CD3/CD28抗體和同種抗原誘導的T瞎報增殖反應。AEB071(<3 μM)可以顯著抑制淋巴細胞功能相關抗原1介導的T細胞的粘附作用。 AEB071(< 20 μM)特異性地降低CD79突變體ABC DLBCL細胞系的增殖,隨之能減少NF-κB信號活性。3 μM 濃度的AEB071可誘導CD79突變細胞在G1阻斷和/或細胞壞死。 |
|||
|---|---|---|---|---|
| 實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
| Western blot |
p-Marcks / p-ERK / p-AKT / p-S6 / Marcks / ERK / AKT / S6
感谢您访问我们的网站,您可能还对以下资源感兴趣: 一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线 | |||